RE: Lupuzor offers Blockbuster Sales potential20 Apr 2022 14:48
I agree the details of the PK study including details such as half life, Cmax, Tmaz Vz for example are not yet known to the market with the new formulation but I take encouragement from the last RNS. Imo their is a higher chance of the FDA approving the phase 3 now as their was no bad news in recent RNS. Yes phase 3 trials take a long time and include several hundred patient across several countries but if a phase 3 is granted it will bring interested Pharma companies, as a lot of the spade work is done. 320p is a wild sp but I don’t think 100mill mcap is out of the question at all once phase 3’s granted